Search
Powered By HealthLine
Special Offers
Health Tools
 Menopause Introduction
 STD Symptoms
 Your Love Life
 Sex Tips & Advice
 STD Prevention
 Ask The Gynecologist
 Safe Sex & STDs
 The Basics of Herpes
 Solve A Sexual Problem
 Herpes Q&A
 The Basics of ED
Featured Conditions
 Breast Cancer
 Erectile Dysfunction
 Menopause
 Incontinence
 Skin Care
 Food & Fitness
 Herpes
 Sexual Health
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
Medical Health Encyclopedia
 border=



Uterus
Uterus
Normal uterine anatomy (cut section)
Normal uterine anatomy (cut section)


Hydatidiform mole

Alternative Names:
Hydatid mole; Molar pregnancy

Treatment:

If a miscarriage does not occur and the diagnosis is confirmed, a therapeutic abortion is performed by suction curettage (D and C).

Text Continues Below



Following either case, serum HCG levels are monitored to assure they return to a normal, non-pregnant level. A hysterectomy may be an option for older women who do not desire future pregnancies.



Expectations (prognosis):

More than 80% of hydatidiform moles are benign (non-cancerous). The outcome after treatment is usually excellent. Close follow-up is essential. Highly effective means of contraception are recommended to avoid pregnancy for at least 6-12 months.

In 10-15% of cases, hydatidiform moles may develop into invasive moles. These may intrude so far into the uterine wall that hemorrhage or other complications develop.

In 2-3% of cases, hydatidiform moles may develop into choriocarcinoma, which is a malignant, rapidly growing, and metastatic (spreading) form of cancer. Despite these factors, which normally indicate a poor prognosis, the rate of cure after treatment with chemotherapy is high.

Over 90% of women with malignant, non-spreading cancer are able to survive and retain their ability to have children. In those with metastatic (spreading) cancer, remission remains at 75-85%, although the ability to have children is usually lost.



Complications:

Page:  1 | 2 | Next >>

 







About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy